uniQure (QURE) Change in Account Payables (2016 - 2026)

uniQure's (QURE) quarterly Change in Account Payables came in at -$557000.0 in Q1 2026, up 73.39% year-on-year from -$321245.8 in Q1 2025, and up 45.34% quarter-over-quarter from -$1.0 million in Q4 2025.

uniQure (QURE) Change in Account Payables (2016 - 2026) Analysis & Trends

uniQure's Change in Account Payables history runs 11 years deep, the most recent figure standing at -$557000.0 for Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 73.39% year-over-year to -$557000.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 983.59% decrease from a year earlier, with the FY2025 full-year figure at -$2.7 million, down 275.46% from the prior year.
  • Change in Account Payables rose to -$557000.0 in Q1 2026 per QURE's latest filing, from -$1.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $7.3 million in Q1 2022 and bottomed at -$3.6 million in Q3 2023.
  • The 5-year median for Change in Account Payables is -$204000.0 (2025), against an average of $197941.2.
  • Across the five-year window, Change in Account Payables jumped 272.49% in 2022 and tumbled 304.45% in 2024, its largest moves.
  • Year by year, Change in Account Payables stood at $4.7 million in 2022, then plunged by 86.94% to $615000.0 in 2023, then soared by 230.41% to $2.0 million in 2024, then sank by 150.15% to -$1.0 million in 2025, then soared by 45.34% to -$557000.0 in 2026.
  • Per Business Quant, the three latest QURE Change in Account Payables figures stand at -$557000.0 (Q1 2026), -$1.0 million (Q4 2025), and $649000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 67,132.22 Bn 67,131.94 Bn - -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 973.81 Bn 973.81 Bn - -
4 BeOne Medicines 471.45 Bn 466.66 Bn 1.35 Bn -42.19 Mn
5 Vertex Pharmaceuticals 122.00 Bn 114.75 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 69.99 Bn 61.23 Bn 3.31 Bn -
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.86 Bn 50.67 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn -
10 uniQure 2.41 Bn 2.41 Bn 3.34 Mn -557,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -557,000.00
Mar 31, 2026 -557,000.00
Dec 31, 2025 -1.02 Mn
Dec 31, 2025 -1.02 Mn
Sep 30, 2025 649,000.00
Sep 30, 2025 649,000.00
Jun 30, 2025 -204,000.00
Jun 30, 2025 -204,000.00
Mar 31, 2025 -2.09 Mn
Mar 31, 2025 -2.09 Mn
Dec 31, 2024 2.03 Mn
Dec 31, 2024 2.03 Mn
Sep 30, 2024 1.11 Mn
Sep 30, 2024 1.11 Mn
Jun 30, 2024 -918,000.00
Jun 30, 2024 -918,000.00
Mar 31, 2024 -701,000.00
Mar 31, 2024 -701,000.00
Dec 31, 2023 615,000.00
Dec 31, 2023 615,000.00